4-(4-Fluoro-benzylamino)-3-nitro-benzoic acid methyl ester | 214903-43-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-Fluoro-benzylamino)-3-nitro-benzoic acid methyl ester
• 英文别名: Methyl 4-[(4-fluorophenyl)methylamino]-3-nitrobenzoate
• CAS: 214903-43-2
• 化学式: C₁₅H₁₃FN₂O₄
• 分子量: 304.278
• InChiKey: RJKZEGKWQAYORT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  84.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-(4-Fluoro-benzylamino)-3-nitro-benzoic acid methyl ester 在 sodium hydroxide 、 氯化亚砜 、 水 、 copper diacetate 、 nickel dichloride 、 锌 作用下， 以 甲醇 、 乙醇 、 氯仿 、 水 、 苯 为溶剂， 反应 10.5h， 生成 2-(2-Chloro-phenyl)-1-(4-fluoro-benzyl)-1H-benzoimidazole-5-carboxylic acid (2-dimethylamino-ethyl)-amide
  参考文献：
  名称：

  Synthesis of some new benzimidazolecarboxamides and evaluation of their antimicrobial activity

  摘要：

  A series of 1,2-disubstituted benzimidazole-5(6)-carboxamides was prepared and evaluated in vitro for antimicrobial activity against Staphyloccus aureus, Escherichia coli and Candida albicans. The precursor benzimidazolecarboxylic acids 4a-c and 9a-c were prepared via oxidative condensation of diaminobenzoic acids with aldehydes and via several steps over the 2(1H)-benzimidazolones, respectively. All acids were converted to their acyl chlorides with SOCI2, then amidified with several N,N'-dialkylaminoethyl derivatives. Compounds 8a-c, 20 and 22 exhibited the best activity. (C) 1998 Elsevier Science S.A. All rights reserved.

  DOI：

  10.1016/s0014-827x(98)00045-7
• 作为产物：
  描述：

  4-氟-3-硝基苯甲酸 在 氯化亚砜 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 41.0h， 生成 4-(4-Fluoro-benzylamino)-3-nitro-benzoic acid methyl ester
  参考文献：
  名称：

  Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonist

  摘要：

  The peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor, thought to play a role in energy metabolism, glucose homeostasis and microglia-mediated neuroinflammation. A novel benzimidazole series of centrally penetrant PPAR gamma partial agonists has been identified. The optimization of PPAR gamma activity and in vivo pharmacokinetics leading to the identification of GSK1997132B a potent, metabolically stable and centrally penetrant PPAR gamma partial agonist, is described. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.06.088

文献信息

• Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular <scp>ROS</scp> and triggers apoptosis via mitochondrial pathway
  作者：Jianguo Qi、Jing Huang、Xiaomin Zhou、Wen Luo、Jiaxin Xie、Linqiang Niu、Zhijie Yan、Yang Luo、Yuhui Men、Yanan Chen、Yahong Zhang、Jianhong Wang

  DOI：10.1111/cbdd.13459

  日期：2019.4

  antiproliferative activity with IC50 in the range of 0.19-0.51 μM. The compound inhibited tubulin polymerization and disrupted the microtubule network, leading to G2/M phase arrest. Furthermore, compound 12 induced ROS production and malfunction of mitochondrial membrane potential. Compound 12 led to cancer cells apoptosis in a dose-dependent manner. Western blot analysis showed that compound 12 induced up-regulation

  合成了一系列新颖的喹喔啉衍生物，并评估了它们在三种人类癌细胞系中的抗增殖活性。化合物12表现出最有效的抗增殖活性，IC50在0.19-0.51μM的范围内。该化合物抑制微管蛋白聚合并破坏微管网络，导致G2 / M期停滞。此外，化合物12诱导了ROS的产生和线粒体膜电位的故障。化合物12以剂量依赖性方式导致癌细胞凋亡。蛋白质印迹分析表明，化合物12诱导p21的上调并影响细胞周期相关蛋白的表达。结合模式也通过分子对接来探测。
• Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonist
  作者：Mairi Sime、Amanda C. Allan、Paul Chapman、Charlotte Fieldhouse、Gerard M.P. Giblin、Mark P. Healy、Millard H. Lambert、Lisa M. Leesnitzer、Ann Lewis、Raymond V. Merrihew、Richard A. Rutter、Rosemary Sasse、Barry G. Shearer、Timothy M. Wilson、Robert X. Xu、David J. Virley

  DOI：10.1016/j.bmcl.2011.06.088

  日期：2011.9

  The peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor, thought to play a role in energy metabolism, glucose homeostasis and microglia-mediated neuroinflammation. A novel benzimidazole series of centrally penetrant PPAR gamma partial agonists has been identified. The optimization of PPAR gamma activity and in vivo pharmacokinetics leading to the identification of GSK1997132B a potent, metabolically stable and centrally penetrant PPAR gamma partial agonist, is described. (C) 2011 Elsevier Ltd. All rights reserved.
• Synthesis of some new benzimidazolecarboxamides and evaluation of their antimicrobial activity
  作者：Hakan Göker、Meral Tunçbilek、Gülgün Ayhan、Nurten Altanlar

  DOI：10.1016/s0014-827x(98)00045-7

  日期：1998.6

  A series of 1,2-disubstituted benzimidazole-5(6)-carboxamides was prepared and evaluated in vitro for antimicrobial activity against Staphyloccus aureus, Escherichia coli and Candida albicans. The precursor benzimidazolecarboxylic acids 4a-c and 9a-c were prepared via oxidative condensation of diaminobenzoic acids with aldehydes and via several steps over the 2(1H)-benzimidazolones, respectively. All acids were converted to their acyl chlorides with SOCI2, then amidified with several N,N'-dialkylaminoethyl derivatives. Compounds 8a-c, 20 and 22 exhibited the best activity. (C) 1998 Elsevier Science S.A. All rights reserved.